New and novel treatments for the management of degenerative joint disease, Part 1
Presented by Dr. Janice Huntingford
Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used to treat osteoarthritis (OA) pain, inflammation, and stiffness. With recent advances in treatment, more options are available to provide affected pets with relief from symptoms and greater mobility, thereby improving their quality of life.
PART 1: NEW AND NOVEL TREATMENTS FOR DJD
Most veterinarians would agree that 80% of dogs over 8 years of age have osteoarthritis (OA) when, in fact, most OA is conformational in origin and is often preclinical in at-risk patients. In reality, over half of all dogs are not diagnosed with degenerative joint disease (DJD) until they are approaching end of life. Dr. Janice Huntingford will focus on early diagnosis of DJD, the importance of multimodal therapy, and some of the newer and novel treatments for DJD, including monoclonal antibodies, nutraceuticals, and rehabilitation.
Select one of the following: - Scheduled Event
What is the format of the online event? - Live (Interactive)
Supporting Documentation -
CE Credits - 1
Event Access - Yes